CRYAA antibody (AA 1-80)
-
- Target See all CRYAA Antibodies
- CRYAA (Crystallin, alpha A (CRYAA))
-
Binding Specificity
- AA 1-80
-
Reactivity
- Human, Rat, Mouse
-
Host
- Rabbit
-
Clonality
- Polyclonal
-
Conjugate
- This CRYAA antibody is un-conjugated
-
Application
- Western Blotting (WB), ELISA
- Purpose
- Unconjugated Rabbit polyclonal to CRYAA
- Specificity
- CRYAA Polyclonal Antibody detects endogenous levels of protein.
- Purification
- CRYAA antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
- Immunogen
- Synthesized peptide derived from human CRYAA protein.
- Isotype
- IgG
- Top Product
- Discover our top product CRYAA Primary Antibody
-
-
- Application Notes
- WB 1:500-2000 ELISA 1:5000-20000
- Comment
-
Expressed in eye lens.
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 1 mg/mL
- Buffer
- Liquid form in PBS containing 50 % glycerol,and 0.02 % sodium azide.
- Preservative
- Sodium azide
- Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Storage
- -20 °C
- Storage Comment
- Store at -20°C, and avoid repeat freeze-thaw cycles.
-
- Target
- CRYAA (Crystallin, alpha A (CRYAA))
- Alternative Name
- CRYAA (CRYAA Products)
- Synonyms
- CRYA1 antibody, CTRCT9 antibody, HSPB4 antibody, AI323437 antibody, Acry-1 antibody, Crya-1 antibody, Crya1 antibody, DAcry-1 antibody, lop18 antibody, alpha-a-crystallin antibody, cryaa-A antibody, CRYAA antibody, wu:fc06h04 antibody, zgc:92036 antibody, HspB4 antibody, crystallin alpha A antibody, crystallin, alpha A antibody, alphaA-crystallin antibody, alpha-crystallin A chain-like antibody, crystallin alpha A S homeolog antibody, alpha-crystallin A chain antibody, CRYAA antibody, Cryaa antibody, CpipJ_CPIJ005646 antibody, cryaa antibody, LOC100384978 antibody, cryaa.S antibody, LOC458589 antibody, LOC102724652 antibody
- Molecular Weight
- 19 kDa
- Gene ID
- 102724652
- UniProt
- P02489
- Pathways
- M Phase
-